soft tissue sarcoma

Type: Keyphrase
Name: soft tissue sarcoma
First reported Jul 20 2014 - Updated Jul 20 2014 - 1 reports

Forum Post: Side effects after doxorubicin treatment is finished?

Soft tissue sarcomasA group for anyone affected by any type of soft tissue sarcoma, including those in the fat, muscle, peripheral nerves, synovial sarcomas and angiosarcomas. This is a place to get together, ask questions, share experiences and support ... [Published Macmillan Cancer Support - Jul 20 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 1 reports

BSD Medical initiates Phase I/II soft tissue sarcoma study

BSD Medical Corporation has initiated a Phase I/II study, HYPROSAR, using hyperthermia, delivered using either the BSD-2000 Hyperthermia System or the BSD-500 Hyperthermia System, combined with proton radiotherapy to treat patients with unresectable soft ... [Published Individual.com - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 16 2014 - 4 reports

BSD Medical Hyperthermia starts Hyprosar study to treat Soft Tissue Sarcoma

BSD Medical has started a Phase I/II study (Hyprosar) using hyperthermia, delivered using either the BSD-2000 Hyperthermia System or the BSD-500 Hyperthermia System, combined with proton radiotherapy to treat patients with unresectable soft tissue sa ... [Published Medical Devices Business Review - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Prognostic significance of WT1 expression in soft tissue sarcoma

Soft tissue sarcomas (STS) are rare. We evaluated the WT1 protein expression level in various types of STS and elucidated the value of WT1 as a prognostic factor and a possible therapeutic target.Methods: Immunohistochemical staining for WT1 was performed ... [Published 7thSpace - Jul 16 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Hundreds smile for Smiley

THE Great Lakes community showed their support for local man Jared Wynter on Sunday at the Smile for Smiley benefit. THE Great Lakes community showed their support for local man Jared Wynter on Sunday at the Smile for Smiley benefit. Jared, better known ... [Published Great Lakes Advocate - Jul 16 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

BSD initiates hyperthermia clinical trial

10:42 ET | About: BSD Medical Corporation (BSDM)BSD Medical (BSDM -2.7%) initiates a 28-patient Phase 1/2 clinical trial evaluating the use of hyperthermia combined with proton radiotherapy as a treatment for patients with unresectable soft tissue sarcoma. ... [Published Seeking Alpha - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

3 Health Care Stocks Primed For Big Moves

Throughout the spring, analysts at Lazard Capital and Leerink Swan kept pounding the table for little-known Insmed (Nasdaq: INSM).The analysts kept telling clients that Insmed's Arikace, which is an inhalable antiobiotic used in serious lung infections, ... [Published Yahoo! Finance - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

SMALL CAP SHARE TIPS: Nanobiotix secures funding to fight cancer

This week we cast our net a little wider than normal to look at one of France’s star performing technology stocks.The year to date has been one of incredible progress for Euronext-listed Nanobiotix with the advances reflected in a share price that has ... [Published This Is Money - Jul 14 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Soft Tissue Sarcoma Guidelines: Updated and 'Irradiated'

Soft Tissue Sarcoma: Updated GuidelinesSoft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States this year, and ... [Published Diabetes Care - Jul 11 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Cycle challenge in memory of Henry

A dedicated family is taking on a 272-mile challenge - to honour Lundin Links man Henry Gibbon and raise money for charity at the same time.Eleven family members and friends will travel to John O’ Groats on Saturday, July 19, to start the four-day cycle ... [Published Fife Today - Jul 09 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 1 reports

Latest - Team Ollie Trust set up in memory of four-year-old who died from cancer

A mother who lost her four-year-old son to cancer is to help sick children’s wishes come true by setting up a charity in his name.Sophie Lee, of Cherwell Gardens, Bingham, lost Ollie to a rare form of cancer in February.She is setting up the Team Ollie ... [Published Newark Advertiser - Jul 03 2014]
First reported Apr 28 2014 - Updated Apr 28 2014 - 5 reports

CytRx to Present Completed Phase 1b/2 Progression-Free Survival and Overall Survival Aldoxorubicin Data in Second-Line Soft Tissue Sarcoma at Upcoming Research and Development Day

LOS ANGELES--(EON: Enhanced Online News)--CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it will be presenting updated progression-free survival and overall survival ... [Published EON Business - Apr 28 2014]

Quotes

Dr. Ren continued, "Our development team in Beijing is working closely with our principal investigator and key opinion leaders from leading oncology centers in China in preparation for the trial. We intend to conduct additional trials there as an important component of our China and global integrated development strategy for cost-effective drug development, and to deliver on our mission to bring safer and more effective medicines to patients. We look forward to the continued advancement of ENMD-2076."
...Dr N R Datta presented the basis for the study, "Thermoradiobiological basis of "HYPROSAR": A clinical trial with hyperthermia and proton radiotherapy in unresectable soft tissue sarcoma." During the presentation, Dr Datta stated that studies have demonstrated that hyperthermia increases the efficacy of radiation with minimal morbidity...
...Dr Ken Ren, CEO of CASI, commented, "We are pleased with the Orphan Drug designation as it confirms our belief in the versatility of ENMD-2076 as a promising treatment for HCC, and for other tumor types that we are currently evaluating in the clinic. Orphan drug status also enhances the commercial value of ENMD-2076 to treat HCC, a disease which is difficult to treat. We are finalizing our next steps for ENMD-2076 in HCC and/or in fibrolamellar carcinoma, a subset of HCC and for which there is no treatment available and look forward to advancing our overall development plan for ENMD-2076."

More Content

All (91) | News (62) | Reports (0) | Blogs (25) | Audio/Video (0) | Fact Sheets (0) | Press Releases (3)
sort by: Date | Relevance
Anticancer agent – panobinostat [Published Manufacturing Chemist - Jul 21 2014]
CASI Pharmaceuticals Receives Approval From CFD... [Published Michigan Live - Jul 21 2014]
Forum Post: Side effects after doxorubicin trea... [Published Macmillan Cancer Support - Jul 20 2014]
BSD MEDICAL : Initiates Hyperthermia Clinical S... [Published 4 Traders - Jul 18 2014]
BSD Medical initiates Phase I/II soft tissue sa... [Published Individual.com - Jul 17 2014]
BSD Medical Hyperthermia starts Hyprosar study ... [Published Medical Devices Business Review - Jul 16 2014]
Clinical study will combine hyperthermia with p... [Published MedicalPhysicsWeb - Jul 16 2014]
Prognostic significance of WT1 expression in so... [Published 7thSpace - Jul 16 2014]
Hundreds smile for Smiley [Published Great Lakes Advocate - Jul 16 2014]
Healthcare Review: Aratana Therapeutics, BSD Me... [Published BioMedReports - Jul 15 2014]
Forum Post: Success with doxorubicin? [Published Macmillan Cancer Support - Jul 15 2014]
BSD initiates hyperthermia clinical trial [Published Seeking Alpha - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published BioPortfolio - Jul 15 2014]
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
CASI receives FDA orphan drug designation for h... [Published Individual.com - Jul 14 2014]
3 Health Care Stocks Primed For Big Moves [Published Yahoo! Finance - Jul 14 2014]
The Texas Medical Board vs. Stanislaw Burzynski... [Published ScienceBlogs : Combined Feed - Jul 14 2014]
SMALL CAP SHARE TIPS: Nanobiotix secures fundin... [Published This Is Money - Jul 14 2014]
The Texas Medical Board vs. Stanislaw Burzynski... [Published Science-Based Medicine - Jul 14 2014]
Soft Tissue Sarcoma Guidelines: Updated and 'Ir... [Published Diabetes Care - Jul 11 2014]
Nanobiotix revenues steady; investors focus on ... [Published Proactiveinvestors United Kingdom website - Jul 11 2014]
Cycle challenge in memory of Henry [Published Fife Today - Jul 09 2014]
HCC inhibitor receives FDA orphan drug designation [Published Orthopedics Today - Jul 07 2014]
CASI Pharmaceuticals Receives U.S. Orphan Drug ... [Published Wall Street Select - Jul 07 2014]
CASI Pharmaceuticals Receives U.S. Orphan Drug ... [Published OSIX News - Jul 07 2014]
Latest - Team Ollie Trust set up in memory of f... [Published Newark Advertiser - Jul 03 2014]
Forum Post: RE: Liposarcoma - is this cancer? [Published Macmillan Cancer Support - Jul 01 2014]
Department of Veterans Affairs [Published CNN - Jul 01 2014]
Department of Veterans Affairs Fast Facts [Published KDBC Channel 4 - Jul 01 2014]
Cancer, Marriage, Baby, and My Dog With Epilepsy [Published EverydayHealth.com - Jun 26 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BSD Medical Hyperthermia Reports Initiation of ... [Published Business Wire Health News - Jul 15 2014]
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today reported initiation of a Phase I/II study (HYPROSAR) using ...
The Texas Medical Board vs. Stanislaw Burzynski... [Published ScienceBlogs : Combined Feed - Jul 14 2014]
There’s a point I feel that I have have to make briefly as I begin this post. Basically, this might look familiar, but given that I was at TAM Wednesday through Sunday, I didn’t have time to produce two separate posts, and this is important enough ...
The Texas Medical Board vs. Stanislaw Burzynski... [Published Science-Based Medicine - Jul 14 2014]
As I begin this post, I’m no a miserably crowded, hot, stinky flight winging my way home from TAM . This puts me in the perfect mood to write about my bête noire to conquer all bêtes noires, namely Stanislaw Burzynski, the Polish expat doctor who ...
Nanobiotix revenues steady; investors focus on ... [Published Proactiveinvestors United Kingdom website - Jul 11 2014]
Nanobiotix (EPA:NANO), which is developing a significant advance on traditional radiotherapy, said revenues for the quarter were €48,596 – exactly the same as the comparable period last year. The majority of the income came in an upfront payment from ...
Orphan designation: Ombrabulin, for the: Treatm... [Published Orphan designations - Jun 19 2014]
1 2 3 4 5

Press Releases

sort by: Date | Relevance
NANOBIOTIX: sees Clinical Advance in Soft Tissu... [Published GlobeNewswire: Acquisitions News - Feb 10 2014]
TRACON Pharmaceuticals Initiates Phase 1b Study... [Published GlobeNewswire: Acquisitions News - Feb 03 2014]
Data Presented For ENMD-2076 In Preclinical Mod... [Published PR Newswire - Oct 21 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.